A nurse is assessing an adult client who is receiving morphine via continuous IV infusion. The nurse should identify that which of the following is the priority finding?

A) Respirations deep at a rate of 10/min: This finding indicates respiratory depression, which is a significant concern with morphine administration. Respiratory depression can lead to hypoxia and respiratory arrest, posing a life-threatening situation for the client. Therefore, it is the priority finding that requires immediate intervention, such as reducing the dose of morphine, administering naloxone (an opioid antagonist), or providing respiratory support.

B) Urinary output of 20 mL within 1 hr: While decreased urinary output may indicate potential renal impairment or dehydration, it is not as immediately life-threatening as respiratory depression. However, it should still be monitored and addressed appropriately.

C) Vomiting 30 mL of fluid: Vomiting can be a side effect of morphine but may not require immediate intervention unless it leads to aspiration or dehydration. Nonetheless, it should be closely monitored for complications.

D) Blood pressure 90/60 mm Hg: Hypotension can occur as a side effect of morphine due to its vasodilatory effects. While low blood pressure should be addressed, it is not as immediately life-threatening as respiratory depression. Monitoring and appropriate interventions, such as fluid administration or adjusting the dose of morphine, can be implemented to manage hypotension.

Lansoprazole: Lansoprazole is a proton pump inhibitor commonly used to reduce stomach acid production and treat conditions like gastroesophageal reflux disease (GERD) and ulcers. There are no significant contraindications or interactions between lansoprazole and nitroglycerin. Therefore, it is not contraindicated for use with nitroglycerin.

B) Diazepam: Diazepam is a benzodiazepine medication used to treat anxiety, muscle spasms, and certain seizure disorders. While caution may be necessary when using diazepam concurrently with nitroglycerin due to the potential for additive hypotensive effects, it is not typically contraindicated. However, close monitoring of blood pressure and signs of hypotension is prudent when these medications are used together.

C) Sildenafil: Sildenafil is a phosphodiesterase type 5 (PDE5) inhibitor used to treat erectile dysfunction and pulmonary arterial hypertension. Concomitant use of sildenafil with nitroglycerin is contraindicated due to the risk of profound hypotension, which can result in cardiovascular collapse. Both medications have vasodilatory effects, and their combination can lead to severe hypotension, syncope, and even myocardial infarction. Therefore, sildenafil is contraindicated for use with nitroglycerin.

D) Gemfibrozil: Gemfibrozil is a lipid-lowering medication used to reduce triglyceride levels in individuals with hypertriglyceridemia. There are no significant contraindications or interactions between gemfibrozil and nitroglycerin. Therefore, it is not contraindicated for use with nitroglycerin.